Nina Singh

Clinical Infectious Diseases · 2000–2019

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom Nina Singh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Parkin

Who trusts Nina Singh overall

  1. J. Chastre
  2. 古谷 良輔
  3. J. Fagon
  4. B. Spellberg
  5. 山口 和将

Papers from Nina Singh's perspective

Ordered by how strongly the researchers Nina Singh trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. (Clinical Infectious Diseases)
  2. Echinocandin antifungal drugs. (The Lancet)
  3. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. (Clinical Infectious Diseases)
  4. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (New England Journal of Medicine)
  5. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. (Blood)
  6. Practice Guidelines for Diseases Caused by Aspergillus
  7. Glucocorticoids and invasive fungal infections. (The Lancet)
  8. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. (Clinical Infectious Diseases)
  9. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. (Clinical Infectious Diseases)
  10. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. (Clinical Infectious Diseases)

Their papers